ALB Albemarle Corporation
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.…
Industry Peers
Specialty ChemicalsKey Statistics
About Albemarle (NYSE: ALB)
›
Albemarle (NYSE: ALB) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 7,800 employees.
The shares were at 82.93 USD on 19 November 2026, down 8.6% over 52 weeks. Its 52-week range is 82.65 USD to 221.00 USD, and it trades at the bottom of that range.
At a market capitalisation of 9.79B USD, it trades at 20.0 times trailing earnings and 10.8 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a discount of 41% for ALB. It pays a dividend yielding 1.91% (it pays out 39% of its earnings), against a median of 1.76% among the dividend payers in that peer group.
Albemarle reports return on equity of -5.4%, an operating margin of 17.1% and revenue up 18.8% year over year.
Its debt exceeds its cash by 152.17M USD, a debt-to-equity ratio of 0.35. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 21 analysts cover the stock, with an average rating of Buy; their mean price target of 140.55 USD is 69.5% above the current price. The next earnings report is expected on 10 February 2027.